Management of patients with pulmonary mycobacteriosis in France: a multicenter retrospective cohort study.
Fiche publication
Date publication
octobre 2021
Journal
BMC pulmonary medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BELTRAMO Guillaume
Tous les auteurs :
Bemer P, Peuchant O, Guet-Revillet H, Bador J, Balavoine C, Basille D, Beltramo G, Blanc FX, Blanchard E, Boulanger S, Bourgoin A, Boutoille D, Cambau E, Canis F, Caparros D, Carricajo A, Carrière C, Couetdic G, Couturaud F, Dalphin JC, Degot T, Desquiens M, Devouassoux G, Duez JM, Dumitrescu O, Dupuy-Grasset M, Gaudart A, Georges M, Godet C, Godreuil S, Guillouzouic A, Hamdad-Daoudi F, Héry-Arnaud G, Koebel C, Lagrange A, Lanotte P, Marchand-Adam S, Mougari F, Murris M, Patry I, Pérouse de Montclos M, Raskine L, Risso K, Segonds C, Sicard D, Terru D, Vachée A, Vergnon JM, Martin C, Schramm F, Andrejak C
Lien Pubmed
Résumé
Recent studies report very low adherence of practitioners to ATS/IDSA recommendations for the treatment of nontuberculous mycobacteria pulmonary disease (NTM-PD), as well as a great variability of practices. Type of management could impact prognosis.
Mots clés
Management, Mycobacterium avium complex, Mycobacterium xenopi, Nontuberculous mycobacteria, Prognosis
Référence
BMC Pulm Med. 2021 10 26;21(1):333